Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,104 recruiting studies in this area right now.
By phase
- Not applicable4,205
- Phase 2592
- Phase 1413
- Phase 3328
- Phase 4254
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer225
- Endometrial Cancer210
- Bladder Cancer188
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer112
- Chronic Kidney Disease108
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama153
- Texas119
- Massachusetts117
- New York116
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,104 total
- NCT06182839RecruitingPhase 2
Canagliflozin for advanced kidney disease with MRI study
This trial tests if canagliflozin, a diabetes medication, can help people with very advanced kidney disease or who recently started dialysis. It uses MRI scans to see how the drug affects the heart and kidneys.
Montreal, QuebecAges 18 years+ - NCT06190626Recruiting
A study of eye disease in Zellweger spectrum disorder over time
This study follows people with Zellweger spectrum disorder (ZSD) to understand how their eye condition develops over time. It aims to help doctors treat the disease better in the future.
Rochester, New YorkAges Any age - NCT06200571Enrolling by invitation
Preeclampsia risk study in first-time moms
This study looks at biological changes in first-time mothers who have a high or low risk of developing preeclampsia. It aims to learn more about why preeclampsia happens and how to predict it better.
ÅlesundAges 18 years+ - NCT06202235Recruiting
Magnetic resonance imaging for chronic kidney disease
This trial uses a special MRI technique called multifrequency magnetic resonance elastography (MRE) to see if it can help evaluate chronic kidney disease. It may provide a non-invasive way to monitor kidney health without needing a biopsy.
Shenyang, LiaoningAges 18–65 - NCT06198296RecruitingPhase 1
Armored CAR T cells for GPC3-positive solid tumors
This trial tests a new type of immunotherapy called CAR T cells that are trained to find and attack cancer cells with a specific marker (GPC3). The CAR T cells are also 'armored' with extra proteins (IL-15 and IL-21) to help them work better. It might be an option for adults with advanced solid tumors, especially liver cancer, that have not responded to standard treatments.
Houston, TexasAges Up to 21 years - NCT03736707Recruiting
Testing two breathing machines in very preterm babies
This study compares two ways of helping very preterm infants breathe: a special high-frequency ventilation method versus the standard mechanical ventilator. It aims to see which method works better for preterm babies with breathing failure soon after birth.
Chongqing, Chongqing MunicipalityAges 1 minute–1 hour - NCT06161506RecruitingPhase 2
Electrical stimulation for urinary incontinence after prostate cancer treatment
This trial tests a non-surgical, non-drug treatment that uses gentle electrical stimulation on the skin to help strengthen the muscles that control urine leakage. It's for men who still have urinary incontinence at least 6 months after their prostate cancer treatment.
Bethesda, MarylandAges 18–120 - NCT06157151RecruitingPhase 2
New drug plus pembrolizumab for advanced cervical cancer
This trial tests a new experimental drug, PRGN-2009, combined with the immunotherapy pembrolizumab (Keytruda) for people with HPV-related cervical cancer that has come back or spread. It is for those who have already tried pembrolizumab and are looking for another option.
Little Rock, ArkansasAges 18 years+ - NCT06175832RecruitingPhase 4
Two Hormone Protocols for Egg Growth in First IVF or Egg Freezing
This trial compares two hormone protocols for ovarian stimulation in women having their first cycle—either to freeze eggs for fertility preservation or for IVF with genetic testing. The goal is to see which method leads to more usable eggs while being easier on the patient.
GhentAges 18–40 - NCT06179303RecruitingPhase 2
Imaging to predict response to abemaciclib for advanced breast cancer
This trial tests if a special PET scan can predict how well the drug abemaciclib works for people with advanced hormone receptor-positive, HER2-negative breast cancer. If you qualify, you would receive abemaciclib and have imaging scans to see if your cancer responds.
St Louis, MissouriAges 18 years+ - NCT06158126RecruitingPhase 4
Pregnancy and infant health outcomes study
This study follows pregnant women and their babies to see how well HIV prevention medicines work during pregnancy. It aims to help keep both mother and baby healthy.
LilongweAges 15–55 - NCT06165367Recruiting
Does hyaluronan in the medium improve embryo transfer success?
This trial tests if adding hyaluronan to the liquid used during embryo transfer helps increase the chance of a successful pregnancy. It is for women who have at least one genetically normal embryo (tested with PGT-A) that was frozen on day 5 and are using hormone replacement therapy to prepare the uterus.
Abu Dhabi, Abu Dhabi EmirateAges 18–46 - NCT06173349RecruitingPhase 1
New bladder therapy for BCG-resistant bladder cancer
This trial tests a new treatment for bladder cancer that does not respond to standard BCG therapy. The treatment uses tiny particles (micelles) that deliver a chemotherapy drug directly into the bladder, aiming to destroy cancer cells without needing surgery.
Sacramento, CaliforniaAges 18 years+ - NCT06179771Recruiting
Filter during dialysis or ECMO for severe illness
This study tests a special filter (HA380 column) used during dialysis or ECMO to remove harmful substances from the blood. It is for critically ill patients with severe infection, injury, or breathing problems who also need kidney or lung support.
Leicester, LeicestershireAges 18–65 - NCT06162611RecruitingPhase 4
Emergency contraception with implant and pill
This study tests whether starting the birth control implant (Nexplanon) right after taking emergency contraceptive pills can be a safe and effective way to prevent pregnancy. You might qualify if you've had unprotected sex in the last 3 days and want a long-term birth control option.
Salt Lake City, UtahAges 18–35 - NCT06163469Recruiting
Chlorhexidine bladder wash for people with long-term suprapubic catheters
This study tests whether washing the bladder with a solution called chlorhexidine (a germ-killer) can lower the number of unplanned hospital visits and improve quality of life for people who have a long-term suprapubic catheter. You may be eligible if you have had a catheter for at least a year and have had a recent urinary tract infection.
New Haven, ConnecticutAges 18 years+ - NCT06161324Enrolling by invitation
Home-based rehab for women with bladder leaks
This study tests whether a home exercise program using a smartphone app can help women with stress or mixed urinary incontinence strengthen their pelvic floor muscles and reduce leakage.
Pátrai, AchaiaAges 18–75 - NCT06162689Enrolling by invitation
Mental health study for mothers and families
This study follows up with mothers, children, and co-parents who took part in an earlier mental health study. Researchers want to learn how family mental health changes over time and what factors may help or challenge families.
LondonAges Any age - NCT06180356RecruitingPhase 2
Niraparib after surgery for ovarian cancer with limited spread
This trial is testing a second course of niraparib (a PARP inhibitor) after surgery for ovarian cancer that has come back in just a few spots. It aims to see if restarting niraparib can help keep the cancer from coming back again.
A CoruñaAges 18 years+ - NCT06164613RecruitingPhase 2
Cinnamon for Inducing Labor in First-Time Teen Pregnancies
This study tests whether cinnamon capsules can help start labor in first-time pregnant teens who are full-term. It compares cinnamon to a placebo (fake pill) to see if it is safe and effective for inducing labor.
Tegucigalpa, Francisco Morazán DepartmentAges 14–45 - NCT06158620RecruitingPhase 1/Phase 2
Nasal spray for pain after ureter stent placement
This trial tests whether a nasal spray form of the painkiller ketorolac can safely reduce pain from a ureteral stent after stone surgery. If you are having a ureteroscopy with stent placement, this might help you manage discomfort without stronger medications.
Dallas, TexasAges 18 years+ - NCT06160349Enrolling by invitation
Improving care for new mothers with infection risk
This study asks patients and community experts to share their experiences with infections during pregnancy, delivery, or after birth. Your answers can help hospitals better support mothers and prevent serious illness from infections.
New York, New YorkAges 18 years+ - NCT06173323Recruiting
Improving decision-making for kidney disease patients and their caregivers
This study tests a program to help people with advanced chronic kidney disease (stage 4 CKD) and their caregiver work together on medical decisions. It aims to see if the program improves communication and partnership.
Birmingham, AlabamaAges 18 years+ - NCT04954599RecruitingPhase 1/Phase 2
CP-506 for hard-to-treat cancers with DNA repair defects
This Phase 1/2 study tests CP-506 in people with advanced solid tumors that have specific DNA repair problems (homologous recombination or Fanconi anemia-related defects). It may be used alone or combined with carboplatin or an immune therapy, aiming to shrink tumors or improve control when standard options are limited.
BrusselsAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,104 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,983 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.